Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer
To access this article, please choose from the options below
N.K. has nothing to disclose. K.S.R. has nothing to disclose. T.L.N. has nothing to disclose.
Presented at the 55th Annual Scientific Meeting of the Pacific Coast Reproductive Society, Rancho Mirage, California, April 18–22, 2007.
Conflict of Interest: the randomized study of different forms of vaginal progesterone supplementation was sponsored by Ferring Pharmaceuticals, Inc. Drs. Blake and Yankov are employees of Ferring Pharmaceuticals, Inc.
PII: S0015-0282(08)00747-4
doi:10.1016/j.fertnstert.2008.03.072
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

